A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.

MLA

Pellegrini, Evelin, et al. “A Natural Product, Voacamine, Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells.” Toxicology and Applied Pharmacology, vol. 434, Jan. 2022, p. 115816. EBSCOhost, https://doi.org/10.1016/j.taap.2021.115816.

APA

Pellegrini, E., Multari, G., Gallo, F. R., Vecchiotti, D., Zazzeroni, F., Condello, M., & Meschini, S. (2022). A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells. Toxicology and Applied Pharmacology, 434, 115816. https://doi.org/10.1016/j.taap.2021.115816

Chicago

Pellegrini, Evelin, Giuseppina Multari, Francesca Romana Gallo, Davide Vecchiotti, Francesca Zazzeroni, Maria Condello, and Stefania Meschini. 2022. “A Natural Product, Voacamine, Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells.” Toxicology and Applied Pharmacology 434 (January): 115816. doi:10.1016/j.taap.2021.115816.